Sign Out
As 2nd-line therapy when diet, exercise and initial treatment with a sulfonylurea or metformin do not result in adequate glycemic control in patients with type 2 diabetes with HbA1c >8%.
Glucovance 1.25 mg/250 mg, Glucovance 2.5 mg/500 mg: Initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes with glycosylated hemoglobin (HbA1c) >8% whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone.
